Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA Mismatch-Reference-Cited by-同舟云学术

Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA Mismatch

Published:2020-05 Issue:5 Volume:104 Page:1070-1080
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Al Malki Monzr M.,Gendzekhadze Ketevan,Yang Dongyun,Mokhtari Sally,Parker Pablo,Karanes Chatchada,Palmer Joycelynne,Snyder David,Forman Stephen J.,Nademanee Auayporn,Nakamura Ryotaro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference23 articles.

1. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. Registry.;Gragert;N Engl J Med,2014

2. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.;Lee;Blood,2007

3. HLA mismatch is associated with worse outcomes after unrelated donor reduced-intensity conditioning hematopoietic cell transplantation: an analysis from the center for international blood and marrow transplant research.;Verneris;Biol Blood Marrow Transplant,2015

4. Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors.;Petersdorf;Tissue Antigens,2007

5. HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category.;Woolfrey;Biol Blood Marrow Transplant,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation;Frontiers in Immunology;2024-09-12

2. Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease: A Multicenter Chart Review Study;Hematology Reports;2024-05-06

3. Itacitinib Population Pharmacokinetics and Exposure‐Response in Patients With Acute Graft‐Versus‐Host Disease;The Journal of Clinical Pharmacology;2023-01-30

4. New strategies for mismatched unrelated donor (MMUD) hematopoietic cell transplant (HCT);Hematology;2022-12-09

5. Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis;Frontiers in Oncology;2022-10-06